The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients

Figure 5

ROC curve for different studied markers to discriminate estrogen-sensitive (group 1) and estrogen-resistant (groups 2 and 3).